BrightInsight stock

BrightInsight Stock


Looking to sell BrightInsight stock or options?

Contact us
Founded: 2018Funding to Date: $182M
Visit website

BrightInsight has developed a digital health platform designed to enhance the optimization of regulated drugs, devices, and software via integrated data and actionable insights. The company's platform employs software and services to secure, transmit, and analyze data from FDA-regulated and CE-marked medical devices, combination products, apps, and software as a medical device, adhering to security, privacy, and regulatory standards. This enables biopharma and med-tech companies to speed up their market entry, lower the costs of implementation and scaling across products, and expand into global markets.

Investors include:
Insight Partners logo
Further Key Investors:

New Leaf Venture, Sand Hill Angels, Alpha Partners, General Catalyst, Gaingels, OurCrowd, Horizon Technology Finance BDC, PROOF, Eclipse Ventures.